Literature DB >> 7114377

Lymphatic spread and its prognostic value in patients with rectal cancer.

K Hojo, Y Koyama, Y Moriya.   

Abstract

The incidence of lymph node metastasis in 423 patients with resected rectal cancer was 51.4 percent. There was no correlation between the size of the tumor and metastasis when the maximum diameter of the tumor exceeded 3 cm, and metastasis was seen in more than 50 percent of the patients. Metastasis was seen in 17.9 percent of the patients with cancer limited to the mucosa (mucosal and submucosal layer), in 37.8 of those with penetration limited to the propria muscle, and in more than 50 percent of those with penetration to the serosa or invasion into other organs. With lower rectal cancer, lateral metastasis was seen in 23 percent of the patients with advanced cancer, and inguinal lymph node metastasis in 6 percent. The 5 year survival rate of Dukes' C patients was as low as 33 percent, but was 52.9 percent in the patients with metastasis to only the pararectal lymph node; the prognosis of lateral metastasis is poor. As a subclassification of Dukes' C, levels 1, 2, 3, 4, and 5 are proposed on the basis of the extent of lymphatic spread.

Entities:  

Mesh:

Year:  1982        PMID: 7114377     DOI: 10.1016/0002-9610(82)90018-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  37 in total

Review 1.  Locally recurrent rectal cancer: surgical strategy.

Authors:  J P de Azevedo; R R Dozois; L L Gunderson
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

Review 2.  Chemoradiotherapy and adjuvant chemotherapy for rectal cancer.

Authors:  Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

3.  Lateral lymph node dissection for lower rectal cancer.

Authors:  T Nakamura; M Watanabe
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Authors:  Seok-Byung Lim; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seong Ho Park; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2013-08-14       Impact factor: 2.571

5.  Incidence and Predictive Model for Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer.

Authors:  Kapil Dev; K V Veerenderkumar; Swamyvelu Krishnamurthy
Journal:  Indian J Surg Oncol       Date:  2018-02-04

6.  Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.

Authors:  Soichiro Ishihara; Yukihide Kanemitsu; Koji Murono; Kensuke Otani; Koji Yasuda; Takeshi Nishikawa; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Hioaki Nozawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2016-05-30       Impact factor: 2.571

Review 7.  Lateral margins of resection in adenocarcinoma of the rectum.

Authors:  B G Wolff
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

8.  Laparoscopic rectal surgery for middle and lower rectal cancer.

Authors:  Yosuke Fukunaga; Masayuki Higashino; Shinnya Tanimura; Masashi Takemura; Yushi Fujiwara
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

9.  Preoperative adjuvant radiation with chemotherapy for rectal cancer: its impact on stage of disease and the role of endorectal ultrasound.

Authors:  A Bernini; K I Deen; R D Madoff; W D Wong
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

10.  Laparoscopic radioisotope-guided sentinel lymph node mapping and excision of the rectum--an experimental study.

Authors:  S Shah; A Scholz; H Reber; M Schreckenberger; R Viebahn; H Lang; M Korenkov
Journal:  Langenbecks Arch Surg       Date:  2009-03-10       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.